EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Geometric Deep Learning for Structure-Based Ligand Design

Alexander S Powers, Helen H Yu, Patricia Suriana, Rohan V Koodli, Tianyu Lu iD, Joseph M Paggi, Ron O Dror iD

ACS Central Science · 27.12.2023 · 9 (12) · 2257-2267

DOI: 10.1021/acscentsci.3c00572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Central Science, online erschienen am 17.11.2023. Verfasst von Alexander S Powers und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Stanford University, Stanford, California 94305, United States. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Division of Graduate Education, National Institute of General Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A pervasive challenge in drug design is determining how to expand a ligand-a small molecule that binds to a target biomolecule-in order to improve various properties of the ligand. Adding single chemical groups, known as fragments, is important for lead optimization tasks, and adding multiple fragments is critical for fragment-based drug design. We have developed a comprehensive framework that uses machine learning and three-dimensional protein-ligand structures to address this challenge. Our method, FRAME, iteratively determines where on a ligand to add fragments, selects fragments to add, and predicts the geometry of the added fragments. On a comprehensive benchmark, FRAME consistently improves predicted affinity and selectivity relative to the initial ligand, while generating molecules with more drug-like chemical properties than docking-based methods currently in widespread use. FRAME learns to accurately describe molecular interactions despite being given no prior information on such interactions. The resulting framework for quality molecular hypothesis generation can be easily incorporated into the workflows of medicinal chemists for diverse tasks, including lead optimization, fragment-based drug discovery, and de novo drug design.

Autor:innen und Institutionen

  • Department of Chemistry, Stanford University, Stanford, California 94305, United States.
  • Department of Computer Science, Stanford University, Stanford, California 94305, United States.
  • Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305, United States.
  • Department of Structural Biology, Stanford University School of Medicine, Stanford, California 94305, United States.
  • Institute for Computational and Mathematical Engineering, Stanford University, Stanford, California 94305, United States.
  • Biomedical Informatics Program, Stanford University School of Medicine, Stanford, California 94305, United States.

ORCID-Profile: Tianyu Lu, Ron O Dror

Förderung

  • NIGMS NIH HHS
  • Division of Graduate Education
  • National Institute of General Medical Sciences

Zitieren

APA

Powers, A. S., Yu, H. H., Suriana, P., Koodli, R. V., Lu, T., Paggi, J. M., & Dror, R. O. (2023). Geometric Deep Learning for Structure-Based Ligand Design. ACS Central Science, 9(12), 2257-2267. https://doi.org/10.1021/acscentsci.3c00572

Vancouver

Powers AS, Yu HH, Suriana P, Koodli RV, Lu T, Paggi JM, et al. Geometric Deep Learning for Structure-Based Ligand Design. ACS Central Science. 2023;9(12):2257-2267. doi:10.1021/acscentsci.3c00572

BibTeX
@article{Powers2023,
  author = {Powers, Alexander S and Yu, Helen H and Suriana, Patricia and Koodli, Rohan V and Lu, Tianyu and Paggi, Joseph M and Dror, Ron O},
  title = {Geometric Deep Learning for Structure-Based Ligand Design},
  journal = {ACS Central Science},
  year = {2023},
  volume = {9},
  number = {12},
  pages = {2257--2267},
  doi = {10.1021/acscentsci.3c00572}
}
Kostenlos starten →